Stereotaxis announced on March 19, 2025, that NVIDIA highlighted its technology at the NVIDIA GTC (GPU Technology Conference), a global artificial intelligence (AI) conference. NVIDIA's Vice President of Healthcare and Life Sciences specifically showcased Stereotaxis’ surgical robots and their efforts to incorporate AI into robotics, signaling a new chapter in medical progress.
In addition to the highlight, Stereotaxis was accepted into the NVIDIA Connect program, which provides member companies with NVIDIA’s software development resources, industry-leading frameworks, and software development kits. This program supports Stereotaxis' pronounced focus on digital solutions that enhance its robotic systems and operating room environment with artificial intelligence, robotic automation, data integration, and decision support capabilities.
Stereotaxis' robotic technologies are at the forefront of advancing robotics in minimally-invasive endovascular surgeries, having been used by physicians at over 100 hospitals globally to treat over 150,000 patients. This collaboration with NVIDIA is expected to dramatically transform what is possible in treating patients by combining robotics' mechanistic benefits with AI innovations.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.